Lioresal

Baclofen, the active ingredient in Lioresal, is a muscle relaxant presented as an intrathecal solution for intrathecal use. It reduces spasticity by acting on the central nervous system and is indicated for patients with multiple sclerosis, spinal cord injury, or cerebral palsy who experience increased muscle tone and involuntary muscle contractions.

GNH USA supplies Lioresal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across all regions.

Baclofen is used to manage spasticity, a condition of increased muscle tone, in several neurological disorders.

Multiple sclerosis: reduces muscle stiffness, decreases spasms, and can improve functional mobility in patients with spasticity related to MS. Spinal cord injury: alleviates involuntary muscle contractions, lowers tone, and supports rehabilitation efforts in individuals with post‑injury spasticity. Cerebral palsy: decreases hypertonia, eases limb rigidity, and assists in motor control for children and adults experiencing spasticity.

Baclofen may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: light‑headed sensation or loss of balance. - Weakness: reduced muscle strength or general fatigue. - Nausea: upset stomach or urge to vomit. - Dry mouth: reduced salivation leading to throat discomfort. - Constipation: difficulty passing stool or infrequent bowel movements.

Serious or Rare Side Effects: - Seizures: occurrence of convulsive episodes. - Respiratory depression: slowed or shallow breathing that may require medical attention. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

When using intrathecal baclofen, clinicians should observe several safety considerations to minimize risks. - Patient selection: assess severity of spasticity and suitability for intrathecal therapy. - Dose titration: initiate at low dose and adjust gradually under medical supervision. - Monitoring: observe for signs of hypotension, respiratory changes, or neurological deterioration. - Contraindications: avoid in patients with known hypersensitivity to baclofen or active infection at the implantation site. - Pregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited. - Store at ambient temperature: keep the solution in the original container, protect from light and freeze, and store below 25 °C.

Baclofen can interact with other medications, affecting its efficacy or safety profile.

Major Interactions (Avoid): - Opioids: combined central nervous system depression may increase risk of respiratory depression. - Benzodiazepines: additive sedative effects can enhance drowsiness and dizziness. - Antihypertensives: may potentiate blood pressure lowering, leading to hypotension.

Moderate Interactions (Monitor Closely): - Anticonvulsants: may alter seizure threshold, requiring dose adjustments. - Alcohol: enhances sedative properties and can worsen dizziness. - CYP450 inhibitors: may affect baclofen metabolism, though limited data exist.